Project description:The purpose of this study is to evaluate the efficacy and safety of naldemedine in the treatment of opioid-induced constipation (OIC) in adults with non-malignant chronic pain who are not using laxatives.

| 2153340 | ecrin-mdr-crc

Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation

| 2155542 | ecrin-mdr-crc

Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age.

Project description: Not available

| S-EPMC7096364 | biostudies-literature

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study.

Project description: Not available

| S-EPMC5916485 | biostudies-literature

Onset of action of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: results from 2 randomized, placebo-controlled, phase 3 trials.

Project description: Not available

| S-EPMC6756260 | biostudies-literature

Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer.

Project description: Not available

| S-EPMC6005145 | biostudies-literature

A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.

Project description: Not available

| S-EPMC5914456 | biostudies-literature

Dataset Information

Naldemedine (Symproic) for the Treatment Of Opioid-Induced Constipation.

Publications

Naldemedine (Symproic) for the Treatment Of Opioid-Induced Constipation.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure